Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Vaccine Development and Evaluation Centre

- PMLiVE

WHO launches R&D efforts to identify pathogens that could cause future pandemics

Over 300 scientists will convene to discuss over 25 virus and bacteria, including ‘Disease X’

- PMLiVE

WHO, WIPO and WTO to hold technical symposium on pandemic preparedness

The event will examine ways to build resilience to be better prepared for future pandemics

- PMLiVE

Act-Accelerator outlines plans for longterm COVID-19 control

Its plan highlights key priorities as countries transition to manage the public health issue

- PMLiVE

UK Government announces £800m boost to support innovation and improve patient safety

The funding will be distributed by the National Institute for Health and Care Research

- PMLiVE

UK Government announces £50m research boost to tackle health inequalities

The investment will be given to 13 local authorities across the UK, from Aberdeen to Plymouth

- PMLiVE

YouGov survey shows global health systems ‘unfit to cope’ with another pandemic

60% of healthcare professionals agree a lack of financial support leaves health systems vulnerable

- PMLiVE

WHO announces new global fund for pandemic prevention and preparedness

Over $1.4bn in financial commitments have already been announced and more are expected in the coming months

- PMLiVE

JCVI publishes statement on London polio vaccination strategy

A total of 116 cases of the virus has been found in London’s wastewater since February

- PMLiVE

UK government’s ‘science superpower’ ambitions to fail without clear plan, Lords committee warns

The House of Lords Science and Technology Committee pointed to a lack of sustained focus, implementation and delivery in realising its 2030 ambitions

- PMLiVE

Biopharma industry launches Berlin Declaration to ensure equal access during future pandemics

The Declaration outlines a framework that could help to ensure that lower-income countries receive pandemic vaccines and treatments

- PMLiVE

UK government invests £175m to ‘supercharge’ clinical research

The £175m adds to the £200m in funding announced earlier this year to strengthen the national data infrastructure

- PMLiVE

Alzheimer’s Research UK supports government plans for clinical research

The charity has suggested creating a Dementia Medicines Taskforce in order to address diseases like Alzheimer's

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links